StockWatch
·
Specialty Chemicals
Board Meeting12 Aug 2026, 04:11 pm

Chemiesynth Board Approves Share Capital Increase & Preference Share Issuance

AI Summary

Chemiesynth (Vapi) Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the increase of authorized share capital from ₹3.25 Crores to ₹18.25 Crores. This includes an increase in equity shares and the introduction of ₹15 Crores in Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) to be issued on a private placement basis. The company also approved the draft of new Articles of Association and scheduled its 40th Annual General Meeting for September 30, 2026. The Board also noted the unaudited financial results for the quarter ended June 30, 2026, and the limited review report.

Key Highlights

  • Authorized share capital increased from ₹3.25 Cr to ₹18.25 Cr.
  • Approval for issuing ₹15 Cr in Unlisted NCRPS via private placement.
  • 40th AGM scheduled for September 30, 2026.
  • New Articles of Association approved, subject to member approval.
  • Unaudited financial results for Q1 FY27 noted.